Learn more Webcast featuring eSpOT-ON
Explore More eSpOT-ON Nuclease Protein Available Now
Explore More Order eSpOT-ON Nuclease mRNA Now

Synthego CRISPRevolution Synthetic Guide RNA Powers CRISPR Genome Research Worldwide

World-class synthetic guide RNA provides faster and more efficient gene editing for scientists around the world

October 18

Redwood City, California – October 18, 2016 – Synthego, a leading provider of genome engineering solutions, today announces its CRISPRevolution products are now shipping to 28 countries, bringing consistent high editing efficiencies to CRISPR researchers globally. Designed to accelerate CRISPR/Cas9, Cpf1 and other novel genome engineering research, Synthego’s products provide researchers with consistency and repeatability in results, increasing efficiency and speeding up the gene editing process. The company’s synthetic guide RNA enables gene editing and gene knockout of up to 90 percent efficiency in cells, is four times faster to transfection readiness, and is up to 80 percent less expensive than competitors.

In just under three months since the launch of Synthego in August, the list of countries to which Synthego is shipping products grew from 8 to 28. The entire list now includes Australia, Belgium, Brazil, Canada, Chile, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Italy, Israel, Japan, Mexico, Netherlands, New Zealand, Norway, United Kingdom, United States, Singapore, Slovenia, South Africa, Spain, Sweden and Switzerland.

"CRISPR genome engineering has taken off across the globe, and now researchers have access to cost-effective world class synthetic guide RNA, which is a critical component in accelerating CRISPR research," said Michael Dabrowski, President of Synthego. "Our intent is to make gene editing more efficient, consistent and cost-effective, helping scientists focus on understanding biology and curing diseases, while reducing unnecessary lab time getting experiments to work."

Synthego is focused on delivering products with the highest editing efficiency, fastest turnaround time, and lowest costs for scientists. The company is able to accomplish this by automating and controlling production quality at each step of the manufacturing process and designing for scale. The company’s flagship product line, CRISPRevolution, is the world’s leading synthetic CRISPR RNA portfolio and includes EZ RNA Kits, sgRNA, custom and modified RNA, and pre-designed libraries.

For more information about Synthego and its products, visit www.synthego.com/products.

About Synthego

Synthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions alongside an expanding molecular and clinical diagnostics portfolio with a mission to accelerate research and development in the pursuit of improved human health. By providing unparalleled access to CRISPR solutions at scale, Synthego enables agility in life science discovery and clinical advancement. With streamlined licensing models, custom manufacturing capabilities and exceptional technical expertise, Synthego empowers researchers and therapeutic developers to unlock better patient outcomes by advancing discovery, diagnostics, and the next generation of advanced therapies.

Media Contact

Greg Huegerich
VP, Marketing
[email protected]